Kaye Alan D, Hollander Alex V, Rogers Brianna N, Thomassen Austin S, Boullion Jolie A, Ly Gianni H, Dorius Bradley, Patel Hirni, Ahmadzadeh Shahab, Shekoohi Sahar, Robinson Christopher L
Departments of Anesthesiology and Pharmacology, Toxicology, and Neurosciences, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, 71103, USA.
School of Medicine, Louisiana State University Health Sciences Center at Shreveport, 1501 Kings Highway, Shreveport, LA, 71103, USA.
Curr Pain Headache Rep. 2025 Jan 4;29(1):7. doi: 10.1007/s11916-024-01356-x.
The rhomboid intercostal and subserratus plane (RISS) block is an effective, safer alternative for managing postoperative acute pain following abdominal surgeries. The RISS block offers several advantages over traditional approaches, including reduced incidence of puncture-related complications, lower rates of systemic opioid consumption, and more consistent analgesic coverage of lower thoracic dermatomes.
Despite a favorable safety profile, the RISS block carries potential risks, such as pneumothorax and local anesthetic systemic toxicity, particularly when long-acting anesthetics such as bupivacaine or ropivacaine are used. Careful administration with ultrasound guidance minimizes these risks, enhancing patient safety. Compared to epidural and paravertebral blocks, RISS is associated with fewer instances of nerve damage, hemodynamic instability, and bleeding. Research suggests that RISS not only improves postoperative pain scores, but also extends duration of analgesic effect, reducing total opioid use by nearly 40%.
Future directions include clinical trials to validate efficacy across diverse patient populations, comparative studies with other regional blocks, and evaluations of long-term outcomes. Expanding our understanding of RISS block application may help advance multimodal pain management protocols, underscoring potential to improve recovery, reduce opioid dependency, and elevate patient quality of life in postoperative settings.
菱形肌间和肋下平面(RISS)阻滞是腹部手术后管理术后急性疼痛的一种有效且更安全的替代方法。与传统方法相比,RISS阻滞具有多种优势,包括穿刺相关并发症的发生率降低、全身性阿片类药物消耗量较低以及对下胸部皮节的镇痛覆盖更一致。
尽管RISS阻滞具有良好的安全性,但仍存在潜在风险,如气胸和局部麻醉药全身毒性,尤其是在使用布比卡因或罗哌卡因等长效麻醉药时。在超声引导下谨慎给药可将这些风险降至最低,提高患者安全性。与硬膜外阻滞和椎旁阻滞相比,RISS阻滞导致神经损伤、血流动力学不稳定和出血的情况较少。研究表明,RISS阻滞不仅能改善术后疼痛评分,还能延长镇痛效果持续时间,使阿片类药物总用量减少近40%。
未来的方向包括开展临床试验以验证在不同患者群体中的疗效、与其他区域阻滞进行比较研究以及评估长期结局。加深我们对RISS阻滞应用的理解可能有助于推进多模式疼痛管理方案,凸显其在改善术后恢复、减少阿片类药物依赖以及提高患者生活质量方面的潜力。